Alswah M - Search Results

1

Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents.

Alswah M, Ghiaty A, El-Morsy A, El-Gamal K. Alswah M, et al. ISRN Org Chem. 2013 Sep 12;2013:587054. doi: 10.1155/2013/587054. eCollection 2013. ISRN Org Chem. 2013. PMID: 24198971 Free PMC article.

2

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.

Alswah M, Bayoumi AH, Elgamal K, Elmorsy A, Ihmaid S, Ahmed HEA. Alswah M, et al. Molecules. 2017 Dec 27;23(1):48. doi: 10.3390/molecules23010048. Molecules. 2017. PMID: 29280968 Free PMC article.

3

Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.

Omar AM, Alswah M, Ahmed HEA, Bayoumi AH, El-Gamal KM, El-Morsy A, Ghiaty A, Afifi TH, Sherbiny FF, Mohammed AS, Mansour BA. Omar AM, et al. Among authors: alswah m. Bioorg Chem. 2020 Mar;96:103656. doi: 10.1016/j.bioorg.2020.103656. Epub 2020 Feb 10. Bioorg Chem. 2020. PMID: 32062449

4

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists.

Ezzat HG, Bayoumi AH, Sherbiny FF, El-Morsy AM, Ghiaty A, Alswah M, Abulkhair HS. Ezzat HG, et al. Among authors: alswah m. Mol Divers. 2021 Feb;25(1):291-306. doi: 10.1007/s11030-020-10070-w. Epub 2020 Mar 12. Mol Divers. 2021. PMID: 32166485

5

Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies.

Aljohani AKB, El Zaloa WAZ, Alswah M, Seleem MA, Elsebaei MM, Bayoumi AH, El-Morsy AM, Almaghrabi M, Awaji AA, Hammad A, Alsulaimany M, Ahmed HEA. Aljohani AKB, et al. Among authors: alswah m. Int J Mol Sci. 2023 Oct 9;24(19):15026. doi: 10.3390/ijms241915026. Int J Mol Sci. 2023. PMID: 37834474 Free PMC article.

6

Design, Synthesis, In Vitro, and In Silico Studies of New N⁵-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors.

Zaki WA, El-Sayed SM, Alswah M, El-Morsy A, Bayoumi AH, Mayhoub AS, Moustafa WH, Awaji AA, Roh EJ, Hassan AHE, Mahmoud K. Zaki WA, et al. Among authors: alswah m. Pharmaceuticals (Basel). 2023 Nov 11;16(11):1593. doi: 10.3390/ph16111593. Pharmaceuticals (Basel). 2023. PMID: 38004458 Free PMC article.

7

Design and discovery of new 1,2,4-triazolo[4,3-c]quinazolines as potential DNA intercalators and topoisomerase II inhibitors.

Alesawy MS, Al-Karmalawy AA, Elkaeed EB, Alswah M, Belal A, Taghour MS, Eissa IH. Alesawy MS, et al. Among authors: alswah m. Arch Pharm (Weinheim). 2021 Mar;354(3):e2000237. doi: 10.1002/ardp.202000237. Epub 2020 Nov 23. Arch Pharm (Weinheim). 2021. PMID: 33226150

8

Design, synthesis, anticancer, and docking of some S- and/or N-heterocyclic derivatives as VEGFR-2 inhibitors.

El-Adl K, Abdel-Rahman AA, Omar AM, Alswah M, Saleh NM. El-Adl K, et al. Among authors: alswah m. Arch Pharm (Weinheim). 2022 Feb;355(2):e2100237. doi: 10.1002/ardp.202100237. Epub 2021 Dec 3. Arch Pharm (Weinheim). 2022. PMID: 34862655

9

5-(4-Methoxybenzylidene)thiazolidine-2,4-dione-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.

El-Adl K, Sakr H, Nasser M, Alswah M, Shoman FMA. El-Adl K, et al. Among authors: alswah m. Arch Pharm (Weinheim). 2020 Sep;353(9):e2000079. doi: 10.1002/ardp.202000079. Epub 2020 Jun 9. Arch Pharm (Weinheim). 2020. PMID: 32515896

10

Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists.

Abdelgawad MA, El-Adl K, El-Hddad SSA, Elhady MM, Saleh NM, Khalifa MM, Khedr F, Alswah M, Nayl AA, Ghoneim MM, Abd El-Sattar NEA. Abdelgawad MA, et al. Among authors: alswah m. Pharmaceuticals (Basel). 2022 Feb 14;15(2):226. doi: 10.3390/ph15020226. Pharmaceuticals (Basel). 2022. PMID: 35215339 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters